vs
Cooper-Standard Holdings Inc.（CPS）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Cooper-Standard Holdings Inc.的1.1倍（$772.1M vs $672.4M），Revvity净利率更高（12.7% vs 0.5%，领先12.2%），Revvity同比增速更快（5.9% vs 1.8%），Revvity自由现金流更多（$161.8M vs $44.6M）
库博标准控股是全球领先的汽车零部件供应商，总部位于美国密歇根州诺维。公司主营产品包括橡塑密封件、燃油管、制动管、流体输送软管以及减震系统，目前在全球20个国家开展业务，拥有约3.2万名员工。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CPS vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.1倍
$672.4M
营收增速更快
RVTY
高出4.1%
1.8%
净利率更高
RVTY
高出12.2%
0.5%
自由现金流更多
RVTY
多$117.2M
$44.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $672.4M | $772.1M |
| 净利润 | $3.3M | $98.4M |
| 毛利率 | 10.4% | — |
| 营业利润率 | 0.1% | 14.5% |
| 净利率 | 0.5% | 12.7% |
| 营收同比 | 1.8% | 5.9% |
| 净利润同比 | -91.7% | 3.9% |
| 每股收益（稀释后） | $0.19 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPSRVTY
| Q4 25 | $672.4M | $772.1M | ||
| Q3 25 | $695.5M | $698.9M | ||
| Q2 25 | $706.0M | $720.3M | ||
| Q1 25 | $667.1M | $664.8M | ||
| Q4 24 | $660.8M | $729.4M | ||
| Q3 24 | — | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | $0 | $649.9M |
净利润CPSRVTY
| Q4 25 | $3.3M | $98.4M | ||
| Q3 25 | $-7.6M | $46.7M | ||
| Q2 25 | $-1.4M | $53.9M | ||
| Q1 25 | $1.6M | $42.2M | ||
| Q4 24 | $40.2M | $94.6M | ||
| Q3 24 | — | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | $-31.7M | $26.0M |
毛利率CPSRVTY
| Q4 25 | 10.4% | — | ||
| Q3 25 | 12.5% | 53.6% | ||
| Q2 25 | 13.2% | 54.5% | ||
| Q1 25 | 11.6% | 56.5% | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率CPSRVTY
| Q4 25 | 0.1% | 14.5% | ||
| Q3 25 | 3.8% | 11.7% | ||
| Q2 25 | 5.3% | 12.6% | ||
| Q1 25 | 3.3% | 10.9% | ||
| Q4 24 | 4.8% | 16.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率CPSRVTY
| Q4 25 | 0.5% | 12.7% | ||
| Q3 25 | -1.1% | 6.7% | ||
| Q2 25 | -0.2% | 7.5% | ||
| Q1 25 | 0.2% | 6.4% | ||
| Q4 24 | 6.1% | 13.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）CPSRVTY
| Q4 25 | $0.19 | $0.86 | ||
| Q3 25 | $-0.43 | $0.40 | ||
| Q2 25 | $-0.08 | $0.46 | ||
| Q1 25 | $0.09 | $0.35 | ||
| Q4 24 | $2.30 | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | $-1.81 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.7M | $919.9M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $-83.5M | $7.3B |
| 总资产 | $1.8B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPSRVTY
| Q4 25 | $191.7M | $919.9M | ||
| Q3 25 | $147.6M | $931.4M | ||
| Q2 25 | $121.6M | $991.8M | ||
| Q1 25 | $140.4M | $1.1B | ||
| Q4 24 | $170.0M | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $114.2M | $1.7B |
总债务CPSRVTY
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.1B | — |
股东权益CPSRVTY
| Q4 25 | $-83.5M | $7.3B | ||
| Q3 25 | $-102.3M | $7.4B | ||
| Q2 25 | $-97.6M | $7.6B | ||
| Q1 25 | $-114.7M | $7.6B | ||
| Q4 24 | $-125.8M | $7.7B | ||
| Q3 24 | — | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | $-115.8M | $7.8B |
总资产CPSRVTY
| Q4 25 | $1.8B | $12.2B | ||
| Q3 25 | $1.9B | $12.1B | ||
| Q2 25 | $1.8B | $12.4B | ||
| Q1 25 | $1.8B | $12.4B | ||
| Q4 24 | $1.7B | $12.4B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | $1.8B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $56.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $44.6M | $161.8M |
| 自由现金流率自由现金流/营收 | 6.6% | 21.0% |
| 资本支出强度资本支出/营收 | 1.7% | 2.6% |
| 现金转化率经营现金流/净利润 | 16.90× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $16.3M | $509.4M |
8季度趋势，按日历期对齐
经营现金流CPSRVTY
| Q4 25 | $56.2M | $182.0M | ||
| Q3 25 | $38.6M | $138.5M | ||
| Q2 25 | $-15.6M | $134.3M | ||
| Q1 25 | $-14.9M | $128.2M | ||
| Q4 24 | $74.7M | $174.2M | ||
| Q3 24 | — | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | $-14.2M | $147.6M |
自由现金流CPSRVTY
| Q4 25 | $44.6M | $161.8M | ||
| Q3 25 | $27.4M | $120.0M | ||
| Q2 25 | $-23.4M | $115.5M | ||
| Q1 25 | $-32.4M | $112.2M | ||
| Q4 24 | $63.2M | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | $-31.0M | $129.7M |
自由现金流率CPSRVTY
| Q4 25 | 6.6% | 21.0% | ||
| Q3 25 | 3.9% | 17.2% | ||
| Q2 25 | -3.3% | 16.0% | ||
| Q1 25 | -4.9% | 16.9% | ||
| Q4 24 | 9.6% | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度CPSRVTY
| Q4 25 | 1.7% | 2.6% | ||
| Q3 25 | 1.6% | 2.6% | ||
| Q2 25 | 1.1% | 2.6% | ||
| Q1 25 | 2.6% | 2.4% | ||
| Q4 24 | 1.7% | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率CPSRVTY
| Q4 25 | 16.90× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | -9.57× | 3.03× | ||
| Q4 24 | 1.86× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPS
| Sealing Systems | $357.8M | 53% |
| Fluid Handling Systems | $297.1M | 44% |
| Corporate And Other Segment | $17.4M | 3% |
| Commercial | $6.6M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
